bioRxivMicrobiologyPreprint
Peptidyl tRNA hydrolase is required for robust prolyl-tRNA turnover in Mycobacterium tuberculosis
F. G. Tomasi, J. T. P. Schweber, S. Kimura, J. Zhu, L. A. T. Cleghorn, S. R. Green, S. H. Davis, M. K. Waldor, E. J. Rubin
Abstract
Enzymes involved in rescuing stalled ribosomes and recycling translation machinery are ubiquitous in bacteria and required for growth. Peptidyl tRNA drop-off is a type of abortive translation that results in the release of a truncated peptide that is still bound to tRNA (peptidyl tRNA) into the cytoplasm. Peptidyl tRNA hydrolase (Pth) recycles the released tRNA by cleaving off the unfinished peptide and is essential in most bacterial species. We developed a sequencing-based strategy called Cu-tRNAseq to study the physiological role of Pth in Mycobacterium tuberculosis (Mtb). While most peptidyl tRNA species accumulated in a strain with impaired Pth expression, peptidyl prolyl-tRNA was particularly enriched, suggesting that Pth is required for robust peptidyl prolyl-tRNA turnover. Reducing Pth levels increased Mtbs susceptibility to tRNA synthetase inhibitors that are in development to treat tuberculosis (TB) and rendered this pathogen highly susceptible to macrolides, drugs that are ordinarily ineffective against Mtb. Collectively, our findings reveal the potency of Cu-tRNAseq for profiling peptidyl tRNAs and suggest that targeting Pth would open new therapeutic approaches for TB.
- organism: bacteria (other)
- assay: proteomics
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: deep learning
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A tRNA-acetylating toxin and detoxifying enzyme in Mycobacterium tuberculosis.
F. G. Tomasi, A. M. J. Hall, … E. J. Rubin·bioRxiv·Dec 20, 2021
- Discovery of small-molecule inhibitors targeting the ribosomal peptidyl transferase center (PTC) of M. tuberculosis
B. Tam, D. Sherf, … B. Akabayov·bioRxiv·Aug 11, 2019
- Elucidation of the essentiality of lumazine synthase (RibH) for Mycobacterium tuberculosis survival and discovery of potent inhibitors for enhanced antimycobacterial therapy
M. Singh, A. Dhanwal, … R. J. Dey·bioRxiv·Jul 18, 2023
- A Novel Actinobacteria-Specific Ribosome Hibernation Factor in Mycobacterium tuberculosis
Soneya Majumdar, Yunlong Li, … Rajendra Kumar Agrawal·bioRxiv·Nov 25, 2024
- A screen of covalent inhibitors in Mycobacterium tuberculosis identifies serine hydrolases involved in lipid metabolism as potential therapeutic targets
B. M. Babin, L. J. Keller, … M. Bogyo·bioRxiv·Jun 7, 2021
- Nucleotidyltransferase toxin MenT targets and extends the aminoacyl acceptor ends of serine tRNAs in vivo to control Mycobacterium tuberculosis growth
X. XU, R. BARRIOT, … P. GENEVAUX·Nature CommunicationsPeer-reviewed·Nov 6, 2024